Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for Anorexia Nervosa
NCT04505189Phase 2Completed
- Sponsor
- Imperial College London
- Start
- May 2021
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of psilocybin in anorexia nervosa (AN), sponsored by Imperial College London. Primary endpoints: Readiness and Motivation Questionnaire at 6 weeks, Eating Disorder Examination at 6 months and 1 more. Started May 2021; status: completed.
02
Drugs
psilocybin
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT04505189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04505189.